...
首页> 外文期刊>Antiviral chemistry & chemotherapy >Inhibition of influenza virus replication by constrained peptides targetingnucleoprotein.
【24h】

Inhibition of influenza virus replication by constrained peptides targetingnucleoprotein.

机译:靶向核蛋白的限制性肽抑制流感病毒复制。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Because of high mutation rates, new drug-resistant viruses arerapidly evolving, thus making the necessary control of influenza virus infection difficult.METHODS: We screened a constrained cysteine-rich peptide library mimickingμ-conotoxins from Conus geographus and a proline-rich peptide library mimickinglebocin 1 and 2 from Bombyx mori by using influenza virus RNA polymerase (PB1,PB2 and PA) and nucleoprotein (NP) as baits.RESULTS: Among the 22 peptides selected from the libraries, we found that theNP-binding proline-rich peptide, PPWCCCSPMKRASPPPAQSDLPATPKCPP, inhibitedinfluenza replicon activity to mean±sd 40.7%±15.8% when expressed as a GFP fusionpeptide in replicon cells. Moreover, when the GFP fusion peptide was transducedinto cells by an HIV-TAT protein transduction domain sequence, the replication ofinfluenza virus A/WSN/33 (WSN) at a multiplicity of infection of 0.01 wasinhibited to 20% and 69% at 12 and 24 h post-infection, respectively. Inaddition, the TAT-GFP fusion peptide was able to slightly protect Balb/c micefrom WSN infection when administrated prior to the infection.CONCLUSIONS: These results suggest the potential of this peptide as the seed ofan anti-influenza drug and reveal the usefulness of the constrained peptidestrategy for generating inhibitors of influenza infection. The results alsosuggest that influenza NP, which is conserved among the influenza A viruses, is agood target for influenza inhibition, despite being the most abundant protein in infected cells.
机译:背景:由于高突变率,新的耐药病毒正在迅速发展,因此难以控制流感病毒的感染。方法:我们筛选了约束的富含半胱氨酸的肽文库,该文库模仿了来自Conus geographus和脯氨酸的肽中的μ-芋螺毒素结果:从文库中选出的22种肽中,我们发现家蚕中的mockinglebocin 1和2是通过流感病毒RNA聚合酶(PB1,PB2和PA)和核蛋白(NP)诱饵而获得的。 PPWCCCSPMKRASPPPAQSDLPATPKCPP,当在复制子细胞中以GFP融合肽表达时,其抑制复制子活性为±sd 40.7%±15.8%。而且,当GFP融合肽通过HIV-TAT蛋白转导结构域序列转导到细胞中时,在感染复数为0.01时,流感病毒A / WSN / 33(WSN)的复制被抑制为在12和24时分别为20%和69%。感染后分别h。此外,在感染前给予TAT-GFP融合肽能够稍微保护Balb / c小鼠免于WSN感染。结论:这些结果表明,该肽具有作为抗流感药物种子的潜力,并揭示了该肽的用途。限制肽策略以产生流感感染抑制剂。该结果还表明,尽管在感染的细胞中蛋白质含量最丰富,但在甲型流感病毒中保守的NP NP是抑制流感的良好靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号